Design of Experiments (DOE) 2017 Before 30 April 50% Discount for its All Seminars

  • Check with publisher
  • Published date: April 24, 2017
    • Washington, DC, USA, United States

Course "Design of Experiments (DOE) for Process Development and Validation" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.
Overview:
Prior to developing a process control plan as part of an overall risk management strategy, process development studies must be completed. The objective of these process development studies is to gain knowledge and understanding about how variation in process parameters explains variation in the product quality characteristics of the product.
The use of DOE methodology provides a means to identify process parameters which impact product quality (Critical Process Parameters) and determine the functional relationship that links the process parameters to those Critical Quality Attributes. Screening designs, such as 2k factorial and D-optimal designs are used to determine critical process parameters. Response surface designs, such as Central Composite Designs (CCDs) and I-optimal designs are used to model the functional relationship between those critical process parameters and the Critical Quality Attributes.
This course will begin by presenting a primer on statistical analysis, focusing on the methods required for analysis of designed experiments. It will then present the steps to DOE, while demonstrating valuable risk management tools (Ishikawa and FMEA) which can be use pre and post DOE studies. Next, participants will learn to generate and analyze multiple screening and response surface designs; the participants will leave with an understanding of why and how each are used. Then, the participants will learn how results of the studies can be presented. Lastly, using the results of the studies, the risk management tools will then be updated.
Why you should attend:
The Global Harmonization Task Force (GHTF) Process Validation Guidance for Medical Device Manufacturers provides guidance on where Design of Experiments should be applied during process validation; it suggests the use of both screening and response surface designs during Operational Qualification. In addition, DOE should be used during multiple phases of design controls: design and development planning, design verification, design validation, design transfer, and design changes.

Location: Washington, DC Date: June 1st & 2nd, 2017and Time: 9:00 AM to 6:00 PM

Venue: Courtyard Arlington Crystal City/Reagan National Airport
Address: 2899 Jefferson Davis Highway Arlington, VA 22202 USA
Price:

Register now and save $200. (Early Bird)
Price: $1,295.00 (Seminar Fee for One Delegate)
Until April 30, Early Bird Price: $1,295.00 From May 01 to May 30, Regular Price: $1,495.00

Register for 5 attendees Price: $3,885.00 $6,475.00 You Save: $2,590.00 (40%)*


Quick Contact:
NetZealous DBA as GlobalCompliancePanel
Phone: 1-800-447-9407
Fax: 302-288-6884
Email: john.robinson@globalcompliancepanel.com
Website: http://www.globalcompliancepanel.com

Registration Link – http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901010SEMINAR?science-marketplace_SEO
Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel
Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/
Follow us on Twitter: https://twitter.com/GCPanel

John Robinson
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • GPC1 ELISA Kit

    GPC1 ELISA Kit

    Clinical/Medical Sciences Shirley (New York ) June 28, 2018 Check with publisher

    Mouse Glypican 1 ELISA Kit kit is a 1.5 hour solid-phase ELISA designed for the quantitative determination of the Glypican 1. This ELISA kit is for research use only, not for therapeutic or diagnostic applications.

  • Webinar On 2018 CPT and HCPCS Updates

    Webinar On 2018 CPT and HCPCS Updates

    Clinical/Medical Sciences Fremont (California) January 16, 2018 Check with publisher

    Training Options Duration: 60 Minutes Tuesday, February 6, 2018 | 10:00 AM PST | 01:00 PM EST Overview: 2018 will see significant changes in each section of the CPT and HCPCS manuals. There have been over 350 code changes with the update. This hour-l...

  • Anti-FUT3 (clone cBR96)-hydrazone-doxorubicin ADC

    Anti-FUT3 (clone cBR96)-hydrazone-doxorubicin ADC

    Clinical/Medical Sciences Shirley (New York) December 18, 2017 Check with publisher

    https://www.creative-biolabs.com/adc/target-fut3-48.htm This ADC product is comprised of an anti-FUT3 monoclonal antibody (clone cBR96) conjugated via a hydrazone linker to adoxorubicin. The doxorubicin is targeted to certain cancers by immunerecogni...